ALL patients who received Aucatzyl immunotherapy, made from their own T cells, experienced complete remission within three ...

Immutep's American depositary receipts jumped after the company reported positive data from a trial evaluating its drug Efti in combination with Merck's therapy Keytruda for treating non-small cell ...